Clinical trial condition

CIN3

Explore clinical trials studying CIN3. Study availability and eligibility vary by location and protocol.

9 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

CIN3 trial results

Recruiting

Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa

NCT05413798

Conditions: CIN2, CIN3, Cervical Cancer, +13 more
Locations: Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospital Westdene, Johannesburg, South Africa

View Trial Details

Recruiting

Regression of Cervical Precancerous Lesions and Associated Risk Factors

NCT06147388

Conditions: CIN2, CIN3, Cervix Uteri SIL, +1 more
Locations: General University Hospital Prague, Czechia

View Trial Details

Recruiting

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT04422366

Conditions: AIS, CIN1, CIN2, +45 more
Locations: Liuzhou center for disease control and prevention Liuzhou, Guangxi, China

View Trial Details

Recruiting

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

NCT05371353

Conditions: CIN1, CIN2, CIN3, +36 more
Locations: Yangchun Center For Disease Prevention And Control Yangchun, Guangdong, China

Center for Disease Control and Prevention Mianyang, Sichuan, China

View Trial Details

Recruiting

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

NCT05027776

Conditions: CIN1, CIN2, CIN3, +36 more
Locations: Center for Disease Control and Prevention Mianyang, Sichuan, China

View Trial Details

Not Yet Recruiting

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

NCT07545746

Conditions: Blood-Borne Infections, CIN, CIN1, +39 more
Locations: Maseno University Kisumu, Kenya

Nyanza Reproductive Health Society Kisumu, Kenya

View Trial Details

Completed

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

NCT05413811

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, CIN2, +29 more
Locations: Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospital Westdene, Johannesburg, South Africa

View Trial Details

Completed

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT05372016

Conditions: AIS, CIN1, CIN2, +46 more
Locations: Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Guangxi, China

View Trial Details

Completed

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT04425291

Conditions: AIS, CIN1, CIN2, +45 more
Locations: Yangchun Center For Disease Prevention And Control Yangchun, Guangdong, China

View Trial Details

CIN3

CIN3 trial results

Related conditions